- Report
- April 2024
- 137 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- August 2024
- 140 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- May 2024
- 135 Pages
Global
From €6178EUR$6,499USD£5,190GBP
- Report
- May 2024
- 134 Pages
Global
From €6178EUR$6,499USD£5,190GBP
- Report
- May 2024
- 131 Pages
Global
From €6178EUR$6,499USD£5,190GBP
- Report
- May 2024
- 140 Pages
Global
From €6178EUR$6,499USD£5,190GBP
- Report
- May 2024
- 134 Pages
Global
From €6178EUR$6,499USD£5,190GBP
- Report
- May 2024
- 129 Pages
Global
From €6178EUR$6,499USD£5,190GBP
- Report
- May 2024
- 133 Pages
Global
From €6178EUR$6,499USD£5,190GBP
- Report
- May 2024
- 137 Pages
Global
From €6178EUR$6,499USD£5,190GBP
- Report
- May 2024
- 133 Pages
Global
From €6178EUR$6,499USD£5,190GBP
- Clinical Trials
- December 2024
- 60 Pages
Global
From €1426EUR$1,500USD£1,198GBP
- Drug Pipelines
- July 2024
- 150 Pages
Global
From €3565EUR$3,750USD£2,995GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1188EUR$1,250USD£998GBP
- Clinical Trials
- April 2024
- 50 Pages
Global
From €1426EUR$1,500USD£1,198GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1188EUR$1,250USD£998GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1188EUR$1,250USD£998GBP
- Clinical Trials
- April 2024
- 50 Pages
Global
From €1426EUR$1,500USD£1,198GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1426EUR$1,500USD£1,198GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1426EUR$1,500USD£1,198GBP

The Antifungal Drug market is a subset of the larger Infectious Diseases Drugs market. Antifungal drugs are used to treat fungal infections, which can range from mild to life-threatening. These drugs work by either killing the fungus or preventing its growth. Common antifungal drugs include azoles, polyenes, and echinocandins. Azoles are the most commonly prescribed antifungal drugs, and are used to treat a wide range of fungal infections. Polyenes are used to treat more serious fungal infections, while echinocandins are used to treat severe fungal infections.
The Antifungal Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, Merck, Novartis, GlaxoSmithKline, and AstraZeneca. Other companies in the market include Bayer, Sanofi, Allergan, and Johnson & Johnson. Show Less Read more